Rotterdam, Androgen Excess Society ve National Institutes of Health Kriterlerine Göre Tanı Alan Polikistik Over Sendromlu Hastaların Biyokimyasal Değerleri ve İnsülin Direncinin Karşılaştırılması

Objective: There are different criteria to diagnose polycystic ovary syndrome (PCOS) such as Rotterdam Consensus, Androgen Excess Society (AES), and National Institutes of Health (NIH). We aimed investigate the biochemical insulin resistance-related markers PCOS patients according diagnostic criteria.
 Material methods: 1299 admitted our clinic retrospectively analyzed. Following inclusion exclusion criteria, 200 with (Group 1), 182 AES 2), 180 NIH 3) were included in study. Results: Waist/hip ratio among all groups (p1 = 0.002; p2 0.0001; p3 0.0001), LH/FSH between Group 1 3 (p2=0.017), AST 2 (p3 =0.012), DHEA-S modified Ferriman–Gallwey score 0.041; p1 0.013, respectively) (p2= 0.003; 0.04, significantly different. A significant difference was detected body mass index ≥ 25 (kg/m2) (p 0.006). waist circumference 88 cm 0.0001, 0.0012, 0.004). 
 Conclusion: The rate metabolic found be higher diagnosed resistance dyslipidemia criteria. However, these differences not statistically significant.